Bluesight introduces ShortageCheck to manage drug inventories in hospitals

Wed, Aug 20, 2025, 10:37 AM 2 min read

Hospital intelligence solutions provider Bluesight has launched ShortageCheck technology designed to assist health systems and hospitals in tracking, forecasting and managing drug inventories.

ShortageCheck integrates real-time inventory data, predictive analytics, and collaborative planning tools into a comprehensive platform.

This innovation is poised to ensure that caregivers and patients have uninterrupted access to essential medications.

Monitoring over 20 real-time market signals, encompassing demand spikes and fulfilment delays, ShortageCheck provides coverage across more than 2,500 acute care facilities across the US.

It identifies early warning signs of drug shortages, offering up to a 90-day lead time, with an average of 42 days, allowing healthcare institutions to prepare and adapt their inventory management strategies.

By assessing levels of inventory, usage rates along with days-on-hand, the platform offers in-depth insights into the potential impact of each shortage.

This enables organisations to evaluate risk, prioritise responses and leverage ShortageCheck's communication tools for cross-team coordination and planning.

Bluesight CEO and co-founder Kevin MacDonald said: “Shortage management has been one of, if not the most critical, pain point for our customers over the last six years. When drug shortages hit without warning, it forces teams to scramble for alternatives, and patient care ultimately suffers.

“With improving health system operations as our top priority, the launch of ShortageCheck marks a significant milestone in ensuring customers have the solutions needed to get ahead of shortages before they hit, preserving labour hours and costs during a time when drug costs are rising, staff shortages persist, and medicare reimbursement changes are on the horizon.”

ShortageCheck is part of the hospital intelligence solutions suite of Bluesight, which includes CostCheck, KitCheck, 340BCheck, ControlCheck and PrivacyPro.

These tools collectively offer hospitals the capability to restock inventory quicker, reduce drug expenditure, streamline audit preparations, pinpoint drug diversion more effectively, and save time in protecting patient privacy.

This January, Bluesight expanded its capabilities by acquiring Protenus, a healthcare compliance analytics platform provider.

"Bluesight introduces ShortageCheck to manage drug inventories in hospitals" was originally created and published by Hospital Management, a GlobalData owned brand.

The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.